Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 5935-5950
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.5935
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.5935
Figure 1 The Barcelona clinic liver cancer algorithm for the management of hepatocellular carcinoma, adapted from Bolondi et al[140].
HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization.
- Citation: Colecchia A, Schiumerini R, Cucchetti A, Cescon M, Taddia M, Marasco G, Festi D. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol 2014; 20(20): 5935-5950
- URL: https://www.wjgnet.com/1007-9327/full/v20/i20/5935.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.5935